ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

Scientists create the first mutant ants – Washington Post

Continue reading

2017-08-10 Michael Zand NEWS

UCSD team adapts CRISPR to edit RNA for disease therapies – The San Diego Union-Tribune


Washington Post

Scientists create the first mutant ants
Washington Post
Using the CRISPR-Cas9 technique, with bacterial molecules acting like scissors to snip out genes, the scientists knocked out a crucial component of the ant’s odor receptors. Pheromones, the odors by which ants communicate, are their social medium.

and more »

Continue reading

2017-08-10 Michael Zand NEWS

Dozens of New Genes with Resistance to Cancer Immunotherapy Discovered – Immuno-Oncology News


The San Diego Union-Tribune

UCSD team adapts CRISPR to edit RNA for disease therapies
The San Diego Union-Tribune
Scientists led by UC San Diego’s Gene Yeo modified CRISPR so it doesn’t target DNA and instead attacks specific RNA sequences, while leaving others alone. This specificity is vital for therapeutic purposes. It is delivered by an adenovirus, a virus …
RNA-targeting CRISPR could yield treatments for Huntington’s, ALSFierceBiotech
CRISPR Corrects RNA-based Disease DefectsThe Scientist
Researchers Use CRISPR to Destroy Pathogenic RNA Species Linked to Huntington’s Disease, ALSGenomeWeb
Phys.Org –KPBS
all 6 news articles »
Continue reading

2017-08-10 Michael Zand NEWS

Dozens of New Genes with Resistance to Cancer Immunotherapy Discovered – Immuno-Oncology News


Immuno-Oncology News

Dozens of New Genes with Resistance to Cancer Immunotherapy Discovered
Immuno-Oncology News
“We cast a wide, deep net and conducted an unbiased survey of all of the 19,000 genes in the cancer’s genome – not just the genes that are known to be involved in creating immunotherapy-resistant tumors,” Nicholas P. Restifo, MD, said in a press release.

Continue reading

2017-08-10 Michael Zand NEWS

Immunotherapy treatment shown safe in type 1 diabetes clinical trial – CBS News

CBS NewsImmunotherapy treatment shown safe in type 1 diabetes clinical trialCBS NewsA small clinical trial showed an immune system therapy was safe for people with type 1 diabetes, British researchers report. The immunotherapy also showed signs of help… Continue reading

2017-08-10 Michael Zand NEWS

Cancer’s Newest Miracle Cure – TIME


Immuno-Oncology News

Dozens of New Genes with Resistance to Cancer Immunotherapy Discovered
Immuno-Oncology News
“We cast a wide, deep net and conducted an unbiased survey of all of the 19,000 genes in the cancer’s genome – not just the genes that are known to be involved in creating immunotherapy-resistant tumors,” Nicholas P. Restifo, MD, said in a press release.

Continue reading

2017-08-10 Michael Zand NEWS

Test results after stem cell transplant for multiple myeloma can confuse patients and doctors about – Medical Xpress

Medical XpressTest results after stem cell transplant for multiple myeloma can confuse patients and doctors aboutMedical XpressSophisticated laboratory tests used to both diagnose the disease then follow treatment response, can send confusing messages … Continue reading

2017-08-10 Michael Zand NEWS

Across China: Stem cell recipient, donor meet 13 years after transplant – Xinhua

Across China: Stem cell recipient, donor meet 13 years after transplantXinhuaCHONGQING, Aug. 10 (Xinhua) — Until last week, leukemia survivor Fengfeng (not his real name) knew almost nothing about the person who saved his life 13 years ago. Holding a … Continue reading

2017-08-10 Michael Zand NEWS
  • 1
  • …
  • 1,372
  • 1,373
  • 1,374
  • 1,375
  • 1,376
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

TIME

Cancer’s Newest Miracle Cure
TIME
What makes immune-based therapies like CAR T cell therapy so promising–and so powerful–is that they are a living drug churned out by the patients themselves. The treatment isn’t a pill or a liquid that has to be taken regularly, but a one-hit wonder …

and more »